12/20/2023 0 Comments Soho notes convert![]() In the absence of a vaccine that protects against the COVID-19 virus, there has been an increased public awareness to maintaining good health, including the demand for products offered by SOHO. Along with the COVID-19 pandemic, the demand for healthcare products and services has increased rapidly around the world, including Indonesia. Rayendra said that the pharmaceutical industry in Indonesia has enormous growth potential supported by stable economic growth, a supportive demographic profile and government support in developing the industry. In overall, SOHO will issue 553,290,122 shares with market capitalization of IDR 2.3 trillion. Tobing, explained that along with this Initial Public Offering, SOHO will also issue new shares in the context of implementing the Management Incentive Program, warrants conversion and convertible notes conversion. Mid-year 2020, because of the consumer it serves under the current pandemic, Imboost has grown by more than 100%,” added Cooey.ĭirector, Head of Investment Banking, PT Indo Premier Sekuritas, Rayendra L. Imboost is ranked among the most valuable brands in the pharmaceutical industry in terms of revenue and has been growing by an average of 25% each year for the past seven years. Our flagship brand, Imboost, is one hugely successful example in the immunity segment. "Driven by reliable R&D and a deep understanding of the healthcare industry in Indonesia, we continue to innovate to bring new products to market. SOHO is also one of the few national companies in Indonesia that consistently maintains a global standard of good corporate governance. These achievements have proven SOHO's ability and reliability to execute business strategies and face challenges in a volatile and rapidly changing business environment. Together, thereby create a Healthier Indonesia at the same time remain committed to consistently generate value for all our shareholders”.Ĭooey added, SOHO has recorded sales growth of over 10% for the past 3 years, and achieved a 40.7% increase in sales during the first 6 months of 2020. ![]() We are committed to continue to take aggressive proactive steps to deliver better on the needs of consumers, with more products that urgently serve patients and customers, and that they deliver better health outcomes. "We are very pleased to have successfully completed the Company's IPO. Therefore, all proceeds from the IPO will be used by SOHO to strengthen its distribution business, the strategic asset for SOHO as well as the enabler for SOHO’s other business segments. SOHO President Director and Chief Executive Officer, Rogelio Paulino Jr La ‘O (Cooey), said that the IPO was a significant milestone for SOHO to strengthen its position in the pharmaceutical and healthcare sector in Indonesia. The number of shares offered was 114,380,700 shares or 13.78% of total issued and paid-up capital of the Company after Initial Public Offering. SOHO has set an offering price of Rp1,820 per share and has gone through the public offering process on September 2 – 3, 2020. Jakarta, September 8th, 2020 - PT Soho Global Health Tbk (ticker code: SOHO), a leading national company in the healthcare sector with a history of more than 70 years in Indonesia, today made an Initial Public Listing (IPO) on Indonesia Stock Exchange and became the 42nd listed company this year or the 705th of total listed companies. 08 September 2020 PRESS RELEASE – INITIAL PUBLIC OFFERING PT SOHO GLOBAL HEALTH TBK (SOHO)
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |